GLA and Nager acrofacial dysostosis: In summary, the diagnosis of AFD in this patient was based on a suggestive clinical phenotype (recurrent strokes, cardiac hypertrophy, and renal dysfunction), biochemical confirmation of low α-galactosidase A activity, and the identification of a potentially relevant GLA variant (p.D313Y), supporting the clinical decision to initiate specific therapy.